FindMyKOL
Clinical trialNCT00686933CompletedPhase 2Interventional

Long Term Safety and Tolerability Study of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

SponsorAbbVie (prior sponsor, Abbott)Enrollment117Attention-Deficit/Hyperactivity Disorder
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The objective of this study is to evaluate the long-term effects and tolerability of ABT-089 in adults with Attention-Deficit/Hyperactivity Disorder (ADHD).
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Site Reference Id/investigator# 8315

    Lafayette, California, United States

  • Site Reference Id/investigator# 8306

    Jacksonville, Florida, United States

  • Site Reference Id/investigator# 8308

    Orlando, Florida, United States

  • Site Reference Id/investigator# 8314

    Overland Park, Kansas, United States

  • Site Reference Id/investigator# 8307

    Farmington Hills, Michigan, United States

  • Site Reference Id/investigator# 8318

    Troy, Michigan, United States

  • Site Reference Id/investigator# 8309

    Eugene, Oregon, United States

  • Site Reference Id/investigator# 8316

    Portland, Oregon, United States

  • Site Reference Id/investigator# 8310

    Memphis, Tennessee, United States

  • Site Reference Id/investigator# 8319

    Virginia Beach, Virginia, United States

  • Site Reference Id/investigator# 8305

    Bellevue, Washington, United States

  • Site Reference Id/investigator# 8320

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

ABT-089
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 May 2008
Primary completion
31 Oct 2008
Completion
31 Oct 2008
Last update posted
21 Jan 2013
Registered enrollment
117
Registry id
NCT00686933
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.